238 related articles for article (PubMed ID: 2105340)
1. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
Carano A; Teitelbaum SL; Konsek JD; Schlesinger PH; Blair HC
J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
[TBL] [Abstract][Full Text] [Related]
2. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
Sato M; Grasser W
J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
[TBL] [Abstract][Full Text] [Related]
3. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
David P; Nguyen H; Barbier A; Baron R
J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group.
Boonekamp PM; Löwik CW; van der Wee-Pals LJ; van Wijk-van Lennep ML; Bijvoet OL
Bone Miner; 1987 Feb; 2(1):29-42. PubMed ID: 3504722
[TBL] [Abstract][Full Text] [Related]
5. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ
J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
[TBL] [Abstract][Full Text] [Related]
6. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp PM; van der Wee-Pals LJ; van Wijk-van Lennep MM; Thesing CW; Bijvoet OL
Bone Miner; 1986 Feb; 1(1):27-39. PubMed ID: 3508715
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
[TBL] [Abstract][Full Text] [Related]
8. Effects of two novel bisphosphonates on bone cells in vitro.
Evans CE; Braidman IP
Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
[TBL] [Abstract][Full Text] [Related]
9. The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.
Piper K; Boyde A; Jones SJ
Calcif Tissue Int; 1994 Jan; 54(1):56-61. PubMed ID: 8118755
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-term low-dose diphosphonate treatment on rat bone.
Evans RA; Howlett CR; Dunstan CR; Hills E
Clin Orthop Relat Res; 1982 May; (165):290-9. PubMed ID: 6210482
[TBL] [Abstract][Full Text] [Related]
11. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
[TBL] [Abstract][Full Text] [Related]
12. Etidronate (EHDP) inhibits osteoclastic-bone resorption, promotes apoptosis and disrupts actin rings in isolate-mature osteoclasts.
Hiroi-Furuya E; Kameda T; Hiura K; Mano H; Miyazawa K; Nakamaru Y; Watanabe-Mano M; Okuda N; Shimada J; Yamamoto Y; Hakeda Y; Kumegawa M
Calcif Tissue Int; 1999 Mar; 64(3):219-23. PubMed ID: 10024379
[TBL] [Abstract][Full Text] [Related]
13. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
van der Pluijm G; Löwik CW; de Groot H; Alblas MJ; van der Wee-Pals LJ; Bijvoet OL; Papapoulos SE
J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
Flanagan AM; Chambers TJ
Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
[TBL] [Abstract][Full Text] [Related]
16. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
17. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.
Flanagan AM; Chambers TJ
Bone Miner; 1989 Apr; 6(1):33-43. PubMed ID: 2526673
[TBL] [Abstract][Full Text] [Related]
18. Reversible inhibition of osteoclastic activity by bone-bound gallium (III).
Blair HC; Teitelbaum SL; Tan HL; Schlesinger PH
J Cell Biochem; 1992 Apr; 48(4):401-10. PubMed ID: 1577877
[TBL] [Abstract][Full Text] [Related]
19. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
Nicolin V; Bareggi R; Baldini G; Bortul R; Martinelli B; Narducci P
Acta Histochem; 2007; 109(5):397-402. PubMed ID: 17574655
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
Sato M; Grasser W; Endo N; Akins R; Simmons H; Thompson DD; Golub E; Rodan GA
J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
